These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24136146)

  • 1. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.
    Goeppert B; Frauenschuh L; Zucknick M; Stenzinger A; Andrulis M; Klauschen F; Joehrens K; Warth A; Renner M; Mehrabi A; Hafezi M; Thelen A; Schirmacher P; Weichert W
    Br J Cancer; 2013 Nov; 109(10):2665-74. PubMed ID: 24136146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer.
    Goeppert B; Frauenschuh L; Zucknick M; Roessler S; Mehrabi A; Hafezi M; Stenzinger A; Warth A; Pathil A; Renner M; Schirmacher P; Weichert W
    Br J Cancer; 2015 Nov; 113(9):1343-9. PubMed ID: 26461054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.
    Ling A; Edin S; Wikberg ML; Öberg Å; Palmqvist R
    Br J Cancer; 2014 May; 110(10):2551-9. PubMed ID: 24675384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.
    Goeppert B; Roessler S; Becker N; Zucknick M; Vogel MN; Warth A; Pathil-Warth A; Mehrabi A; Schirmacher P; Mollenhauer J; Renner M
    Histopathology; 2017 Jun; 70(7):1064-1071. PubMed ID: 28130841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High CD8
    Koemans WJ; van Dieren JM; van den Berg JG; Meijer GA; Snaebjornsson P; Chalabi M; Lecot F; Riedl R; Krijgsman O; Hofland I; Broeks A; Voncken FEM; Peppelenbosch MP; Sosef MN; van Sandick JW; Kodach LL
    Histopathology; 2021 Aug; 79(2):238-251. PubMed ID: 33660299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.
    Han S; Zhang C; Li Q; Dong J; Liu Y; Huang Y; Jiang T; Wu A
    Br J Cancer; 2014 May; 110(10):2560-8. PubMed ID: 24691423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
    Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J
    World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Dickkopf-1 and ß-catenin expression according to the antitumor immunity of CD8-positive tumor-infiltrating lymphocytes in biliary tract cancer.
    Kim SR; Won HS; Yang JH; Sun S; Yim K; Hong M; Hong SA; Yoon JS; Chun SH; Kim KH; Ko YH
    Sci Rep; 2022 Feb; 12(1):1931. PubMed ID: 35121803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.
    Ino Y; Yamazaki-Itoh R; Shimada K; Iwasaki M; Kosuge T; Kanai Y; Hiraoka N
    Br J Cancer; 2013 Mar; 108(4):914-23. PubMed ID: 23385730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer.
    Kim HD; Kim JH; Ryu YM; Kim D; Lee S; Shin J; Hong SM; Kim KH; Jung DH; Song GW; Hwang DW; Lee JH; Song KB; Ryoo BY; Jeong JH; Kim KP; Kim SY; Yoo C
    Cancer Res Treat; 2021 Jan; 53(1):162-171. PubMed ID: 32878426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of immune cell infiltration within gallbladder cancer.
    Nakakubo Y; Miyamoto M; Cho Y; Hida Y; Oshikiri T; Suzuoki M; Hiraoka K; Itoh T; Kondo S; Katoh H
    Br J Cancer; 2003 Nov; 89(9):1736-42. PubMed ID: 14583778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis.
    Charbel A; Tavernar L; Albrecht T; Brinkmann F; Verheij J; Roos E; Vogel MN; Köhler B; Springfeld C; Brobeil A; Schirmacher P; Singer S; Mehrabi A; Roessler S; Goeppert B
    Br J Cancer; 2022 Nov; 127(9):1603-1614. PubMed ID: 36068277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma.
    Pretscher D; Distel LV; Grabenbauer GG; Wittlinger M; Buettner M; Niedobitek G
    BMC Cancer; 2009 Aug; 9():292. PubMed ID: 19698134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer.
    Verma R; Hanby AM; Horgan K; Verghese ET; Volpato M; Carter CR; Hughes TA
    Breast Cancer Res Treat; 2020 Aug; 183(1):49-59. PubMed ID: 32577938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome.
    Mansuri N; Birkman EM; Heuser VD; Lintunen M; Ålgars A; Sundström J; Ristamäki R; Lehtinen L; Carpén O
    Virchows Arch; 2021 Apr; 478(4):707-717. PubMed ID: 32954467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
    Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW
    Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
    Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
    Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
    Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C
    BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma.
    Fukunaga A; Miyamoto M; Cho Y; Murakami S; Kawarada Y; Oshikiri T; Kato K; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Itoh T; Morikawa T; Okushiba S; Kondo S; Katoh H
    Pancreas; 2004 Jan; 28(1):e26-31. PubMed ID: 14707745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.